Life Sciences Tools & Services
Price
$150.86
+0.59%Market Cap
$42.7B
Day High
$151.59
Day Low
$147.78
In Q3 FY2026, company A grew revenue 8% and operating income 23%, while integrating the Biocare acquisition and managing tariff-related headwinds.
Key risk: Tariffs and trade policy uncertainty
The filing highlights that additional tariffs, scope and duration of which remain uncertain, and potential trade war escalation could materially harm results. Management has mitigated some cost impacts through supply chain optimization and pricing actions, but judicial and regulatory developments continue to pose uncertainty.
Other Life Sciences Tools & Services companies